Seguir
Luis Henrique Canani
Luis Henrique Canani
Universidade Federal do Rio Grande do Sul
Email confirmado em hcpa.edu.br
Título
Citado por
Citado por
Ano
Diabetic nephropathy: diagnosis, prevention, and treatment
JL Gross, MJ De Azevedo, SP Silveiro, LH Canani, ML Caramori, ...
Diabetes care 28 (1), 164-176, 2005
26682005
Sotagliflozin in patients with diabetes and chronic kidney disease
DL Bhatt, M Szarek, B Pitt, CP Cannon, LA Leiter, DK McGuire, JB Lewis, ...
New England Journal of Medicine 384 (2), 129-139, 2021
8642021
Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes
MG Pezzolesi, GD Poznik, JC Mychaleckyj, AD Paterson, MT Barati, ...
Diabetes 58 (6), 1403-1410, 2009
3412009
Oral semaglutide versus empagliflozin in patients with type 2 diabetes uncontrolled on metformin: the PIONEER 2 trial
HW Rodbard, J Rosenstock, LH Canani, C Deerochanawong, ...
Diabetes care 42 (12), 2272-2281, 2019
3352019
Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies
CK Kramer, TC Rodrigues, LH Canani, JL Gross, MJ Azevedo
Diabetes care 34 (5), 1238-1244, 2011
2752011
Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes
LA Costa, LH Canani, HRK Lisboa, GS Tres, JL Gross
Diabetic Medicine 21 (3), 252-255, 2004
2732004
The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus
LH Canani, C Capp, JM Dora, ELS Meyer, MS Wagner, JW Harney, ...
The Journal of Clinical Endocrinology & Metabolism 90 (6), 3472-3478, 2005
2332005
Coronary artery calcium score prediction of all cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis
CK Kramer, B Zinman, JL Gross, LH Canani, TC Rodrigues, MJ Azevedo, ...
Bmj 346, 2013
1892013
The role of the uncoupling protein 1 (UCP1) on the development of obesity and type 2 diabetes mellitus
LA Brondani, TS Assmann, GCK Duarte, JL Gross, LH Canani, D Crispim
Arquivos Brasileiros de Endocrinologia & Metabologia 56, 215-225, 2012
1792012
Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients.
LH Canani, F Gerchman, JL Gross
Diabetes 48 (4), 909-913, 1999
1591999
Prevalência de complicações micro e macrovasculares e de seus fatores de risco em pacientes com diabetes melito do tipo 2 em atendimento ambulatorial
RS Scheffel, D Bortolanza, CS Weber, LA Costa, LH Canani, KG Santos, ...
Revista da Associação Médica Brasileira 50, 263-267, 2004
1552004
Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients
CB Leitao, LH Canani, CK Kramer, JC Boza, AF Pinotti, JL Gross
Diabetes care 30 (5), 1255-1260, 2007
1512007
Efficacy and safety of topiramate on weight loss: a meta‐analysis of randomized controlled trials
CK Kramer, CB Leitao, LC Pinto, LH Canani, MJ Azevedo, JL Gross
Obesity reviews 12 (5), e338-e347, 2011
1502011
Meta-Analysis Reveals the Association of Common Variants in the Uncoupling Protein (UCP) 1–3 Genes with Body Mass Index Variability
LA Brondani, TS Assmann, BM de Souza, AP Boucas, LH Canani, ...
PloS one 9 (5), e96411, 2014
1402014
Clinical and laboratory profile of patients with type 2 diabetes with low glomerular filtration rate and normoalbuminuria
CK Kramer, CB Leitão, LC Pinto, SP Silveiro, JL Gross, LH Canani
Diabetes care 30 (8), 1998-2000, 2007
1382007
A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes
AS Krolewski, GD Poznik, G Placha, L Canani, J Dunn, W Walker, ...
Kidney international 69 (1), 129-136, 2006
1322006
Nitric oxide system and diabetic nephropathy
BS Dellamea, CB Leitão, R Friedman, LH Canani
Diabetology & metabolic syndrome 6, 1-6, 2014
1302014
The role of uncoupling protein 2 (UCP2) on the development of type 2 diabetes mellitus and its chronic complications
BM Souza, TS Assmann, LM Kliemann, JL Gross, LH Canani, D Crispim
Arquivos Brasileiros de Endocrinologia & Metabologia 55, 239-248, 2011
1252011
Nitric oxide levels in patients with diabetes mellitus: A systematic review and meta-analysis
TS Assmann, LA Brondani, AP Boucas, J Rheinheimer, BM de Souza, ...
Nitric Oxide 61, 1-9, 2016
1192016
The human peroxisome proliferator-activated receptor γ2 (PPARγ2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes
ML Caramori, LH Canani, LA Costa, JL Gross
Diabetes 52 (12), 3010-3013, 2003
1162003
O sistema não pode efectuar a operação agora. Tente mais tarde.
Artigos 1–20